The civic record
Read. Follow. Verify.Alabama HB 364 Requires Physicians and Nurse Practitioners to Discuss Opioid Risks Before Initial and Third Prescriptions
Last action · January 29, 2026: Pending Committee Action in House of OriginSponsor: Greg Barnes
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
Alabama health care professionals with prescription authority must discuss addiction risks, alternative treatments, and specific prescribing reasons with patients before issuing an initial and a third prescription for a or opioid pain relief drug, starting October 1, 2026.
Patients receiving certain controlled substances will receive specific risk disclosures and alternative treatment information unless exempt due to cancer, hospice care, long-term care residency, or substance abuse treatment.
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
physicians
Physicians with prescription authority must conduct and document specific risk discussions before issuing initial and third prescriptions for certain controlled substances.
nurse practitioners
Certified registered nurse practitioners engaged in collaborative practice must conduct and document specific risk discussions before issuing initial and third prescriptions for certain controlled substances.
patients
Patients receiving initial and third prescriptions for Schedule II controlled substances or opioid pain relief drugs will receive mandatory risk disclosures and alternative treatment information.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
When does the discussion requirement apply?
Are there any patient exemptions from this requirement?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently in committee. The next step in the legislative lifecycle is Floor Vote.
Procedural history
2 actions- Jan 29, 2026HouseCommitteePending Committee Action in House of Origin
- Jan 29, 2026HouseIntroducedRead for the first time and referred to the House Committee on Health
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Connected Entities
Sources
alison.legislature.state.al.us
Analysis Score
0–100- Significance65How much this matters to a regular citizen
- Controversy25Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz20Current news / social attention level
Publisher tools